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Background
Changes in left ventricular compliance caused by diffuse
fibrosis after MI may result in diastolic dysfunction and
left atrial enlargement. We sought to test the hypothesis
that left atrial volume is associated with ECV (a marker of
diffuse myocardial fibrosis) during the sub-acute phase of
infarction and can predict the increase of ECV during the
ensuing months of infarct healing. We quantified left atrial
volumes serially in patients after ST-elevation myocardial
infarction and assessed their relationship with indices of
post-MI remodeling including left ventricular dimensions,
ECV, and infarct size.
Methods
Sixty-seven patients underwent gadolinium-enhanced
cardiac magnetic resonance (CMR) imaging serially at 2-4
weeks and 6 months after STEMI. Left atrial volumes
(LAV) were calculated at the end of ventricular systole
(LAVmax), just before atrial contraction (LAVbac), and at
the end of ventricular diastole (LAVmin) using the biplane
area-length method. Using a segmented, breath-held
Look-Locker sequence in 3 short axis slices, T1 measure-
ments were made pre- and post-contrast up to 30 minutes
after administration of gadolinium (gadopentetate dime-
glumine, 0.15 mmol/kg). Regression of myocardial R1
(defined as 1/T1) against R1 of the blood pool was used to
determine the gadolinium partition coefficient, which
when multiplied by (1-hematocrit/100), to estimate ECV.
Total infarct size was measured using a full-width half
maximum (FWHM) methodology and was expressed in
total grams and %LGE.
Results
Patients were predominantly male (83%), with a mean
age of 58±11 years, and had a mean LVEF of 53±10%
(see Table 1). Mean ECV was 0.35 ± 0.07 at the baseline
scan. LAV demonstrated a strong positive correlation
with ECV (r=0.48, p=0.002), and this relationship main-
tained after adjustment to patient age and LVEDV
(p=0.01). LAV was also positively correlated to infarct
size at baseline (r=0.44, p=0.0071). Progression of LAV
demonstrated a strong correlation with the progression
of ECV expansion during the 6 months of infarct
healing (r=0.47, P=0.004).
Conclusions
Large left atrial volume is associated with expansion of
the extracellular matrix early after infarction, and its
progression reflects alteration of ECV during infarct
healing. We postulate that left atrial volume sensitively
reflects diastolic ventricular stiffness early and during
infarction remodeling.
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Table 1 Baseline characteristics
Sex
Male 83%
Female 17%
Age 58±10
Medication use
Beta-blocker 94%
ACE inhibitor 84%
Statin 97%
Comorbidities
Diabetes 21%
Hypertension 60%
Dyslipidemia 66%
Tobacco Use 51%
LVEF 52±10%
RVEF 54±7%
LV mass (grams) 118±36
LVEDV 164±47
LVESV 88±44
All values expressed as means or percentages, as appropriate.
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